Top compounds associated with response to TUFM


Feature Type Standardized
Nominal ANOVA
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.062 0.07
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.066 0.07
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.07
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.059 0.07
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.062 0.07
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.068 0.07
mRNA Vandetanib CCLE pan-cancer AAC -0.083 0.08
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA GW843682X CTRPv2 pan-cancer AAC 0.063 0.08
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.22 0.08
Download CSV